Blue Latitude Health Wins PMEA 2015 award for Innovation

Blue Latitude Health's Medical Information Cascade project, for Eli Lilly and Company, won the PMEA 2015 award for Innovation


LONDON, UK, - 26th November 2015 – Blue Latitude Health, a creative marketing consultancy specialising in healthcare, last night won a PMEA 2015 award for their project on Lilly's Medical Information Cascade, which was shortlisted for Innovation. The PMEA awards, which were presented at a black tie dinner at the Lancaster London Hotel, recognise and commend excellence, best practice and innovation in local, European and international healthcare markets.

Fred Bassett, Co-Founder and Head of Strategy, Blue Latitude Health, said, "We're thrilled to have won the prestigious PMEA Award for Innovation and see our work honoured at PMEA 2015. Strategy and innovative solutions are at the heart of everything we do at Blue Latitude Health. The Medical Information Cascade project combined SEO tactics, user-centred design methodologies, and the provision of capability training to deliver a first line medical information portal online – the first of its kind."
He added, "Our customer experience, creative services and strategic teams always look to transform how our clients engage with healthcare professionals and patients. I credit our talented and experienced team and our overall vision to improve customer experience in the healthcare sector for this award."

Suggested Articles

The FDA wants to know what, exactly, is in a drug name—and whether it influences how the product is perceived. So it's launching a study to find out.

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.